Jeffrey D. Benner

Also affiliated with Io Therapeutics (United States), NIHR Research Delivery Network, Auburn University, Salisbury University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Low-Dose Intravitreal Methotrexate for Proliferative Vitreoretinopathy”.

Low-Dose Intravitreal Methotrexate for Proliferative Vitreoretinopathy

Ophthalmic surgery, lasers & imaging retina(2023)10.3928/23258160-20230220-01

N/A

0DataRank · unranked

23 citations

Cynthia A. Toth, Henry W. Burnett, John W. Butler, Jay H. Levy, Jeffrey D. Benner +1 more

Fentanyl‐induced respiratory depression in rodents is inhibited by bioabsorbable, subcutaneous naltrexone implants at 3.5 months

Addiction Biology(2023)10.1111/adb.13350

N/A

0DataRank · unranked

3 citations

Steven M. Cohen, Joseph A. Hollenbaugh, Marc Fishman, Jeffrey D. Benner

Bioabsorbable, subcutaneous naltrexone implants mitigate fentanyl‐induced respiratory depression at 3 months—A pilot study in male canines

Physiological Reports(2024)10.14814/phy2.16176

N/A

0DataRank · unranked

3 citations

Joseph A. Hollenbaugh, Donald D'Aquila, Marc Fishman, Steven M. Cohen, Veera Holdai +2 more